BANGKOK (AP) — Stocks edged lower in Asia on Tuesday after a mixed finish on Wall Street, as investors weighed the risks of inflation against signs the recovery from the pandemic is gaining momentum.
Benchmarks fell in Tokyo, Hong Kong and Shanghai and were flat in Seoul.
In a subdued opening to the week in New York, the S&P 500 slipped less than 0.1%, giving up some recent gains. The benchmark index is within 0.2% of the all-time high it reached a month ago.
Japan reported that its economy contracted at a 5.1% annual pace in January-March, revised upward from the earlier reported 6.3% contraction. On a quarterly basis, the economy shrank 1% instead of the preliminary minus 1.3%.
A worsening coronavirus outbreak that has caused the government to declare a partial state of emergency and tighten pandemic precautions is likely to keep the economy in the doldrums in the currenct quarter, Makoto Tsuchiya of Oxford Economics said in a commentary.
“However, we remain optimistic that the pace of recovery will pick up in the second half as domestic demand recovers, supported by increased vaccinations, while foreign demand should continue to support the manufacturing sector,” he said.
Hong Kong’s Hang Seng lost 0.3% to 28,713.42 and the Nikkei in Tokyo edged 0.1% lower to 28,987.58. The Shanghai Composite index declined 0.4% to 3,584.23 and in Australia the S&P/ASX 200 slipped 0.1% to 7,274,20. In Seoul, the Kospi rose less than 0.1% to 3,254.74.
This is a relatively light week for economic data, though investors will get another glimpse into the impact of inflation on Thursday with the U.S. Labor Department’s consumer price report for May. Prices on everything from food to clothes and housing have been rising as the economy recovers.
Investors and economists are concerned that a steep rise in prices could crimp the recovery and prompt the Federal Reserve to withdraw some of its support for the economy such as keeping interest rates ultra-low and buying bonds.
“The market is treading water right now and waiting for another catalyst to move higher,” said Sam Stovall, chief investment strategist at CFRA.
The S&P 500 fell 3.37 points to 4,226.52. The Dow lost 0.4% to 34,630.24. The Nasdaq rose 0.5% to 13,881.72. The Russell 2000 index of smaller companies gained 1.4% to 2,319.18.
Banks, industrial stocks and materials companies helped pull the broader market lower. Communications companies and health care stocks made solid gains. Facebook rose 1.9%, while drugmaker Moderna rose 6.6% after it sought regulatory authorization in Europe to let adolescents receive its COVID-19 vaccine.
Biogen soared 38.3% for the biggest gain in the S&P 500 after the Food and Drug Administration said it approved the company’s drug for treating Alzheimer’s disease. Biogen’s drug is the first Alzheimer’s disease treatment approved by the FDA in nearly 20 years.
Treasury yields mostly rose. The yield on the 10-year Treasury was steady at 1.57%.
Cruise line operators rose after several companies announced or confirmed plans to start sailing again this summer. The industry essentially shut down during the virus pandemic. Norwegian Cruise Line added 3.1% and Carnival rose 1.1%.
Corporate buyout plans moved several stocks. U.S. Concrete jumped 29.3% after construction materials company Vulcan Materials said it would buy the company. Design software company Autodesk fell 2.1% after announcing plans to pursue a buyout of Altium.
U.S. benchmark crude oil lost 55 cents to $68.68 per barrel in electronic trading on the New York Mercantile Exchange. It lost 39 cents to $69.62 per barrel on Monday. Brent crude, the international standard, declined 57 cents to $70.92 per barrel.
The dollar rose to 109.37 Japanese yen from 109.25 yen. The euro declined to $1.2182 from $1.2192.
AP Business Writers Alex Veiga and Damian J. Troise contributed.
Copyright © 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
More from WTOP
“However, we remain optimistic that the pace of recovery will pick up in the second half as domestic demand recovers, supported by increased vaccinations, while foreign demand should continue to support the manufacturing sector,” he said.Previous